Laboratory Testing for von Willebrand Factor: Factor VIII Binding for the Diagnosis or Exclusion of Type 2N von Willebrand Disease: An Update
Author:
Favaloro Emmanuel J.ORCID,
Mohammed Soma,
Vong Ronny,
Pasalic LeonardoORCID
Reference21 articles.
1. Favaloro EJ (2011) von Willebrand disease: local diagnosis and management of a globally distributed bleeding disorder. Semin Thromb Hemost 37:425–426. https://doi.org/10.1055/s-0031-1281028
2. Sadler JE, Budde U, Eikenboom JCJ, the Working Party on von Willebrand Disease Classification et al (2006) Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor. J Thromb Haemost 4:2103–2114. https://doi.org/10.1111/j.1538-7836.2006.02146.x
3. Favaloro EJ (2020) Classification of von Willebrand disease in the context of modern contemporary von Willebrand factor testing methodologies. Res Pract Thromb Haemost 4(6):952–957. https://doi.org/10.1002/rth2.12392
4. Nichols WL, Hultin MB, James AH et al (2008) von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA). Haemophilia 14:171–232. https://doi.org/10.1111/j.1365-2516.2007.01643.x
5. James PD, Connell NT, Ameer B et al (2021) ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease. Blood Adv 5(1):280–300. https://doi.org/10.1182/bloodadvances.2020003265